Pharmaceutical industry and the life sciences have made great progress utilizing bioinformatics and data science, especially in drug discovery and clinical development, for example in image analysis, large scale genomic analysis, phenotypic profiling and analysis of high dimensional time-series data. More recently, AI and machine learning are being used in pharmacovigilance for the detection of adverse events from social media channels. Another recent use of data analytics on past and present operational data enables insights-driven decision making, increased productivity and trans-parency across a global drug development organization.

Real-world data and real-world evidence are playing an increasing role in health care decisions, for patient access and for policy making. More treatments come to market via expedited regulatory approvals with limited evidence from traditional clinical development programs. Regulatory authorities have a keen interest to accept real-world evidence for marketing authorization, however, the conditions are still a matter of debate.

In this online seminar data science is being approached across the lifecycle, from data generation and data analysis, to data application and decision making, access and policy making. It brings together thought leaders and well-renowned experts from in-dustry, regulatory agencies, health services and patient organizations who will discuss their perspectives and outlook on this rapidly evolving topic.

Join us on June 24, 2021 to learn from and discuss with the experts!

  • June 24, 2021 @ 8:30 am

  • Klingelbergstrasse 61, 4056 Basel, Switzerland - Virtual event

Event starts in
  • 08

  • 07

  • 22


Klingelbergstrasse 61, 4056 Basel, Switzerland - Virtual event

Contact Form